← Back to all trials
Not Yet Recruiting
NCT07008027
Real World Asparaginase Therapy Toxicity
Conditions: Drug Toxicity
Sex: All
Healthy volunteers: No
Enrollment: 200
Sponsor: St. Jude Children's Research Hospital
Location: St. Jude Children's Research Hospital Memphis Tennessee
Summary
This research study is being done to learn more about the short term and long term side effects of treatment with asparaginase drugs, which are commonly used in acute lymphoblastic leukemia (ALL) or acute lymphoblastic lymphoma (LLy) therapy.
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of acute lymphoblastic leukemia, lymphoblastic lymphoma, or mixed phenotype acute leukemia
* Enrolled on INITIALL and no more than 10 days after initiation of post-INITIALL therapy
* Post-INITIALL therapy is:
* Standard of Care (SOC)/Non Protocol Treatment Plan (NPTP) as per Total therapy or
* SJALL23T and not scheduled to receive venetoclax
Exclusion Criteria:
* Inability or unwillingness of research participant or legal guardian/representative to give written informed consent.
Source: ClinicalTrials.gov (NCT07008027). StuddyBuddy aggregates publicly available trial information.
